Earnings Preview For Treace Medical Concepts
Portfolio Pulse from Benzinga Insights
Treace Medical Concepts (NASDAQ:TMCI) is scheduled to release its quarterly earnings report on 2024-02-27, with an estimated EPS of $-0.09. Historical performance shows a significant impact on stock price following earnings announcements, with a notable 37.9% drop after last quarter's miss. Shares are currently trading at $14.25, down 32.9% over the last year, indicating potential investor concern ahead of the earnings release.
February 26, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Treace Medical Concepts is expected to report an EPS of $-0.09 for the upcoming quarter. Historical data shows significant stock price volatility post-earnings, with a 37.9% drop after the last miss. Currently trading at $14.25, down 32.9% over the past year.
Given TMCI's history of significant stock price movements post-earnings and the current downward trend in its year-to-date performance, there's a high likelihood of negative short-term impact if the earnings report fails to meet or exceed expectations. The anticipation of the earnings report, coupled with the company's recent performance history, suggests a cautious outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100